Pseudotumor cerebri. Lumboperitoneal shunt in long lasting cases. 1992

P Angiari, and L Corradini, and M Corsi, and G A Merli
Division of Neurosurgery, Policlinico of USL 16, Modena.

The Authors report three cases of pseudotumor cerebri with noteworthy visual defect. Lumboperitoneal shunt enables good recovery where there was no atrophy of the optic nerve and demonstrated its usefulness also in serious situations.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011559 Pseudotumor Cerebri A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS). Benign Intracranial Hypertension,Idiopathic Intracranial Hypertension,Intracranial Hypertension, Benign,Intracranial Hypertension, Idiopathic,Hypertension, Benign Intracranial,Hypertension, Idiopathic Intracranial
D002557 Cerebrospinal Fluid Shunts Tubes inserted to create communication between a cerebral ventricle and the internal jugular vein. Their emplacement permits draining of cerebrospinal fluid for relief of hydrocephalus or other condition leading to fluid accumulation in the ventricles. Cerebrospinal Fluid Shunt,Shunt, Cerebrospinal Fluid,Shunts, Cerebrospinal Fluid
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014786 Vision Disorders Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132). Hemeralopia,Macropsia,Micropsia,Day Blindness,Metamorphopsia,Vision Disability,Visual Disorders,Visual Impairment,Blindness, Day,Disabilities, Vision,Disability, Vision,Disorder, Visual,Disorders, Visual,Hemeralopias,Impairment, Visual,Impairments, Visual,Macropsias,Metamorphopsias,Micropsias,Vision Disabilities,Vision Disorder,Visual Disorder,Visual Impairments

Related Publications

P Angiari, and L Corradini, and M Corsi, and G A Merli
June 1996, Neurology,
P Angiari, and L Corradini, and M Corsi, and G A Merli
March 1998, Neurology,
P Angiari, and L Corradini, and M Corsi, and G A Merli
September 1997, Neurology,
P Angiari, and L Corradini, and M Corsi, and G A Merli
March 1997, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society,
P Angiari, and L Corradini, and M Corsi, and G A Merli
June 2004, Nippon Ganka Gakkai zasshi,
P Angiari, and L Corradini, and M Corsi, and G A Merli
July 1996, American journal of ophthalmology,
P Angiari, and L Corradini, and M Corsi, and G A Merli
March 2018, Nigerian journal of clinical practice,
P Angiari, and L Corradini, and M Corsi, and G A Merli
May 2000, Journal of clinical anesthesia,
P Angiari, and L Corradini, and M Corsi, and G A Merli
January 2006, JSLS : Journal of the Society of Laparoendoscopic Surgeons,
Copied contents to your clipboard!